Comparing Mavyret vs Sofosbuvir
| Mavyret (glecaprevir / pibrentasvir) | Sofosbuvir |
|
|---|
| Mavyret (glecaprevir / pibrentasvir) | Sofosbuvir |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Mavyret is an antiviral combination tablet that is approved to treat all six genotypes (1-6) of acute or chronic hepatitis C virus (HCV) infection in adults and children 3 years of age and older... View more |
Prescription only
Prescribed for Hepatitis C. Sofosbuvir may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Mavyret (glecaprevir / pibrentasvir) | More about Sofosbuvir | ||||||||
| Ratings & Reviews | |||||||||
|
Mavyret has an average rating of 8.2 out of 10 from a total of 429 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 7% reported a negative effect. |
Sofosbuvir has an average rating of 7.5 out of 10 from a total of 51 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Mavyret side effects |
View all Sofosbuvir side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Mavyret prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
Sovaldi | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
13 hours |
27 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
Category X
Not for use in pregnancy
In Combination With Ribavirin Or Peginterferon Alfa/Ribavirin See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 219 drugs are known to interact with Mavyret:
|
A total of 85 drugs are known to interact with Sofosbuvir:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
August 03, 2017 |
December 06, 2013 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.